Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transfer of a large number of activated NK cells. Here, we report a new effective method to expand human NK cells ex vivo using K562 cells genetically engineered (GE) to express OX40 ligand (K562-OX40L) in combination with a short exposure to soluble IL-21. In addition, we describe a possible mechanism of the NK cell expansion through the OX40 receptor-OX40 ligand axis which is dependent on NK cell homotypic interaction.Methods: K562-OX40L cells were generated by lentiviral transduction and were used as feeder cells to expand and activate NK cells from PBMCs in the presence of IL-2/IL-15. Soluble IL-21 was also added in various concentrations...
The adoptive transfer of highly cytotoxic natural killer (NK) cells is an emerging tool for cancer i...
Contains fulltext : 97724.pdf (publisher's version ) (Open Access)Natural killer (...
It is important to understand which molecules are relevant for linking innate and adaptive immune ce...
Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive ...
Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive ...
Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive ...
Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive ...
DoctorNatural killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transf...
Contains fulltext : 88356.pdf (publisher's version ) (Open Access)Immunotherapy ba...
Contains fulltext : 69789.pdf (publisher's version ) (Closed access)Invariant natu...
AbstractBackground aimsEx vivo expansion of natural killer (NK) cells is a strategy to produce large...
Natural Killer (NK) cells have a crucial role in immune surveillance against a variety of infectious...
Natural Killer (NK) cells have a crucial role in immune surveillance against a variety of infectious...
Small-molecule immunosuppressive drugs (ISD) prevent graft rejection mainly by inhibiting T lymphocy...
Recent advances in cellular therapies for patients with cancer, including checkpoint blockade and ex...
The adoptive transfer of highly cytotoxic natural killer (NK) cells is an emerging tool for cancer i...
Contains fulltext : 97724.pdf (publisher's version ) (Open Access)Natural killer (...
It is important to understand which molecules are relevant for linking innate and adaptive immune ce...
Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive ...
Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive ...
Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive ...
Background: Natural Killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive ...
DoctorNatural killer (NK) cell-based immunotherapy used to treat cancer requires the adoptive transf...
Contains fulltext : 88356.pdf (publisher's version ) (Open Access)Immunotherapy ba...
Contains fulltext : 69789.pdf (publisher's version ) (Closed access)Invariant natu...
AbstractBackground aimsEx vivo expansion of natural killer (NK) cells is a strategy to produce large...
Natural Killer (NK) cells have a crucial role in immune surveillance against a variety of infectious...
Natural Killer (NK) cells have a crucial role in immune surveillance against a variety of infectious...
Small-molecule immunosuppressive drugs (ISD) prevent graft rejection mainly by inhibiting T lymphocy...
Recent advances in cellular therapies for patients with cancer, including checkpoint blockade and ex...
The adoptive transfer of highly cytotoxic natural killer (NK) cells is an emerging tool for cancer i...
Contains fulltext : 97724.pdf (publisher's version ) (Open Access)Natural killer (...
It is important to understand which molecules are relevant for linking innate and adaptive immune ce...